U.S. Senators Express Concerns Over Experimental Zika Vaccine License, Accessibility, Pricing

STAT: More lawmakers want the Army to hold a hearing on Zika vaccine pricing
“A half dozen U.S. senators want the U.S. Army to hold a public hearing to explore the controversy over the pricing of a Zika virus vaccine that Sanofi is developing with taxpayer dollars. In a letter sent on Monday to Acting U.S. Secretary of the Army Robert Speer, the lawmakers expressed concerns that a vaccine would not be ‘accessible and affordable’ for many Americans, since the company may win an exclusive license to develop the technology and have ‘monopolistic’ rights through 2036…” (Silverman, 6/26).